Across TCGA pan-cancer cohorts, MIR520G Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR520G data layer compared with 5 for mass-spec protein.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR520G Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR520G expression acts as an unfavorable survival marker.
SKCM are the cancer types where MIR520G Mutation most reproducibly stratifies survival.